Trial intelligence / Profile preview

Caffeine versus dexmedetomidine for prevention of emergence delirium after sevoflurane anesthesia in children

PACTR202306816155472Recruiting

Sponsor
Mansoura University Children Hospital
Start
Jun 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in Emergence agitation (EA) comparing Dexmedetomidine control group with Caffeine group (2 arms). Primary endpoint: Emergence delirium assessment. Started Jun 2023; status: recruiting.

02

Drugs

caffeinedexmedetomidine
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on PACTR202306816155472.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR202306816155472.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call